Severe delayed autoimmune haemolytic anaemia following artesunate administration in severe malaria: A case report

Malaria Journal

Volumn 13, Issue 1, 2014, Pages

  Raffray, Loic ^a   Receveur, Marie Catherine ^a   Beguet, Mathilde ^c   Lauroua, Pierre ^c   Pistone, Thierry ^a   Malvy, Denis ^a,b  

^a BORDEAUX UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c Aquitaine Limousin Branch of French Blood Institute   (France)

Author keywords

Artesunate; Autoimmune haemolytic anaemia; Severe malaria; Side effects

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; ARTESUNATE; CEFTRIAXONE; CIPROFLOXACIN; CORTICOSTEROID; GENTAMICIN; METRONIDAZOLE; NORADRENALIN; PIPERACILLIN; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE;

ABDOMINAL PAIN; ADOLESCENT; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; BLOOD SMEAR; CASE REPORT; CLINICAL FEATURE; COOMBS TEST; COTE D'IVOIRE; DELAYED HYPERSENSITIVITY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FEVER; HEADACHE; HEMOGLOBIN BLOOD LEVEL; HEMOLYSIS; HUMAN; HYPERLACTATEMIA; MALARIA FALCIPARUM; PARASITEMIA; PHYSICAL EXAMINATION; SEPTIC SHOCK; THROMBOCYTOPENIA; CHEMICALLY INDUCED; FRANCE; MALARIA, FALCIPARUM;

ADOLESCENT; ANEMIA, HEMOLYTIC, AUTOIMMUNE; ANTIMALARIALS; ARTEMISININS; COTE D'IVOIRE; FEMALE; FRANCE; HUMANS; MALARIA, FALCIPARUM;

EID: 84926421876     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-13-398     Document Type: Article

References (26)

1. Askling HH, Bruneel F, Burchard G, Castelli F, Chiodini PL, Grobusch MP, Lopez-Vélez R, Paul M, Petersen E, Popescu C, Ramharter M, Schlagenhauf P: Management of imported malaria in Europe. Malar J 2012, 11:328.
2. Dondorp A, Nosten F, Stepniewska K, Day N, White N: Artesunate versus quinine for treatment of severe falciparum malaria: A randomised trial. Lancet 2005, 366:717-725.
3. Dondorp AM, Fanello CI, Hendriksen ICE, Gomes E, Seni A, Chhaganlal KD, Bojang K, Olaosebikan R, Anunobi N, Maitland K, Kivaya E, Agbenyega T, Nguah SB, Evans J, Gesase S, Kahabuka C, Mtove G, Nadjm B, Deen J, Mwanga-Amumpaire J, Nansumba M, Karema C, Umulisa N, Uwimana A, Mokuolu OA, Adedoyin OT, Johnson WBR, Tshefu AK, Onyamboko MA, Sakulthaew T, et al: Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): An open-label, randomised trial. Lancet 2010, 376:1647-1657.
4. Zoller T, Junghanss T, Kapaun A, Gjorup I, Richter J, Hugo-Persson M, Mørch K, Foroutan B, Suttorp N, Yörek S, Flick H: Intravenous artesunate for severe malaria in travelers, Europe. Emerging Infect Dis 2011, 17:771-777.
5. Kreeftmeijer-Vegter AR, van Genderen PJ, Visser LG, Bierman WFW, Clerinx J, van Veldhuizen CKW, de Vries PJ: Treatment outcome of intravenous artesunate in patients with severe malaria in the Netherlands and Belgium. Malar J 2012, 11:102.
6. Rolling T, Schmiedel S, Wichmann D, Wittkopf D, Burchard G-D, Cramer JP: Post-Treatment haemolysis in severe imported malaria after intravenous artesunate: case report of three patients with hyperparasitaemia. Malar J 2012, 11:169.
7. Kano S: Artemisinin-based combination therapies and their introduction in Japan. J Infect Chemother 2010, 16:375-382.
8. Caramello P, Balbiano R, De Blasi T, Chiriotto M, Deagostini M, Calleri G: Severe malaria, artesunate and haemolysis. J Antimicrob Chemother 2012, 67:2053-2054.
9. Petz L, Garratty G: Immune Hemolytic Anemias. 2nd edition. Philadelphia: Churchill Livingstone; 2004:261-317.
10. Garratty G: Immune hemolytic anemia associated with drug therapy. Blood Rev 2010, 24:143-150.
11. Pham B-N, Gien D, Bensaad F, Babinet J, Dubeaux I, Rouger P, Le Pennec P-Y: Antibodies to co-Trimoxazole (trimethoprim and/or sulfamethoxazole) related to the presence of the drug in a commercial low-ionic-strength solution. Transfusion 2012, 52:844-848.
12. Rolling T, Agbenyega T, Issifou S, Adegnika AA, Sylverken J, Spahlinger D, Ansong D, Löhr SJZ, Burchard GD, May J, Mordmöller B, Krishna S, Kremsner PG, Cramer JP: Delayed hemolysis after treatment with parenteral artesunate in African children with severe malaria-A double-center prospective study. J Infect Dis 2014, 209:1921-1928.
13. Angus BJ, Chotivanich K, Udomsangpetch R, White NJ: In vivo removal of malaria parasites from red blood cells without their destruction in acute falciparum malaria. Blood 1997, 90:2037-2040.
14. Buffet PA, Safeukui I, Deplaine G, Brousse V, Prendki V, Thellier M, Turner GD, Mercereau-Puijalon O: The pathogenesis of Plasmodium falciparum malaria in humans: insights from splenic physiology. Blood 2011, 117:381-392.
15. Dhaliwal G, Cornett PA, Tierney LM Jr: Hemolytic anemia. Am Fam Physician 2004, 69:2599-2606.
16. Guillaud C, Loustau V, Michel M: Hemolytic anemia in adults: main causes and diagnostic procedures. Expert Rev Hematol 2012, 5:229-241.
17. Zantek ND, Koepsell SA, Tharp DR Jr, Cohn CS: The direct antiglobulin test: A critical step in the evaluation of hemolysis. Am J Hematol 2012, 87:707-709.
18. Michel M: Classification and therapeutic approaches in autoimmune hemolytic anemia: An update. Expert Rev Hematol 2011, 4:607-618.
19. Garbe E, Andersohn F, Bronder E, Klimpel A, Thomae M, Schrezenmeier H, Hildebrandt M, Späth-Schwalbe E, Gröneisen A, Mayer B, Salama A, Kurtal H: Drug induced immune haemolytic anaemia in the Berlin case-control surveillance study. Br J Haematol 2011, 154:644-653.
20. Boggs SR, Cunnion KM, Raafat RH: Ceftriaxone-induced hemolysis in a child with Lyme arthritis: A case for antimicrobial stewardship. Pediatrics 2011, 128:e1289-e1292.
21. Kapur G, Valentini RP, Mattoo TK, Warrier I, Imam AA: Ceftriaxone induced hemolysis complicated by acute renal failure. Pediatr Blood Cancer 2008, 50:139-142.
22. Schuettpelz LG, Behrens D, Goldsmith MI, Druley TE: Severe ceftriaxoneinduced hemolysis complicated by diffuse cerebral ischemia in a child with sickle cell disease. J Pediatr Hematol Oncol 2009, 31:870-872.
23. Aloni NM, Nsangu M, Kunuanunua T, Kadima TB, Muanda TF: Hémolyse intravasculaire après prise dartéméther-luméfantrine. Bull Soc Pathol Exot 2010, 103:296-298.
24. Mérat S, Lambert E, Vincenti-Rouquette I, Gidenne S, Rousseau J-M, Brinquin L: Case report: combination artemether-lumefantrine and haemolytic anaemia following a malarial attack. Trans R Soc Trop Med Hyg 2003, 97:433-434.
25. Issitt PD, Anstee DJ: Applied Blood Group Serology. 4th edition. Montgomery: Scientific Publications; 1998.
26. Centers for Disease Control and Prevention (CDC): Published reports of delayed hemolytic anemia after treatment with artesunate for severe malaria-worldwide, 2010-2012. MMWR Morb Mortal Wkly Rep 2013, 62:5-8.